Your browser doesn't support javascript.
loading
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Yardley, Denise A; Young, Robyn R; Adelson, Kerin B; Silber, Andrea L; Najera, Jose E; Daniel, Davey B; Peacock, Nancy; Finney, Lindsey; Hoekstra, Susan J; Shastry, Mythili; Hainsworth, John D; Burris, Howard A.
Afiliação
  • Yardley DA; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN. Electronic address: dyardley@tnonc.com.
  • Young RR; The Center for Cancer and Blood Disorders, Fort Worth, TX.
  • Adelson KB; Yale School of Medicine, New Haven, CT.
  • Silber AL; Yale School of Medicine, New Haven, CT.
  • Najera JE; Cancer Centers of Southwest Oklahoma, Lawton, OK.
  • Daniel DB; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Chattanooga, TN.
  • Peacock N; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN.
  • Finney L; Sarah Cannon Research Institute, Nashville, TN.
  • Hoekstra SJ; Sarah Cannon Research Institute, Nashville, TN.
  • Shastry M; Sarah Cannon Research Institute, Nashville, TN.
  • Hainsworth JD; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN.
  • Burris HA; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN.
Clin Breast Cancer ; 22(3): 269-278, 2022 04.
Article em En | MEDLINE | ID: mdl-34824002

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos Limite: Female / Humans / Male Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores Androgênicos Limite: Female / Humans / Male Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article